![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Liubao Peng
Publisher: Adis International
ISSN: 1170-7690
Source: PharmacoEconomics, Vol.27, Iss.10, 2009-10, pp. : 873-886
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Galsky Matthew D. Pal Sumanta K. Chowdhury Simon Harshman Lauren C. Crabb Simon J. Wong Yu-Ning Yu Evan Y. Powles Thomas Moshier Erin L. Ladoire Sylvain Hussain Syed A. Agarwal Neeraj Vaishampayan Ulka N. Recine Federica Berthold Dominik Necchi Andrea Theodore Christine Milowsky Matthew I. Bellmunt Joaquim Rosenberg Jonathan E. Galsky Matthew D.
Cancer, Vol. 121, Iss. 15, 2015-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Adjuvant regimen with docetaxel best bet in operable breast cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 480, 2005-01 ,pp. :